Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous dendritic cell vaccine for chronic hepatitis B carriers
ChiCTR-TCH-06000560Phase 2Completed
- Sponsor
- Air Force Medical University
- Start
- Mar 2007
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous dendritic cell vaccine in Chronic Hepatitis B (CHB), sponsored by Air Force Medical University. Primary endpoint: HBV DNA. Started Mar 2007; status: completed.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TCH-06000560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TCH-06000560.